The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Structure and expression of dog apolipoprotein A-I, E, and C-I mRNAs: implications for the evolution and functional constraints of apolipoprotein structure.
Abstract
Dog apolipoprotein (apo) C-I, A-I, and E cDNA clones were identified in a dog liver cDNA library in lambda gt10 by hybridization to synthetic oligonucleotide probes with the corresponding human DNA sequences. The longest clone for each apolipoprotein was completely sequenced. The apoC-I cDNA sequence predicts a protein of 62 residue mature peptide preceded by a 26 amino acid signal peptide. The apoA-I cDNA sequence predicts a 242 residue mature peptide, a 6 residue pro-segment, and an 18 residue signal peptide. The apoE cDNA, which lacks the signal peptide region, predicts a mature peptide of 291 amino acid residues. Slot blot hybridization of total RNA isolated from various dog tissues to dog apoC-I, A-I, and E cDNA probes indicates that apoC-I mRNA is detectable in liver only, apoA-I mRNA is present in liver and small intestine, though the concentration in the latter tissue is only approximately 15% of that in the liver, and apoE mRNA is present in multiple tissues including liver, jejunum, urinary bladder, ileum, colon, brain, kidney, spleen, pancreas, and testis with relative concentrations (%) of 100, 17.5, 7.5, 6.9, 5.9, 5.5, 5.0, 3.3, 1.0, and 1.0, respectively. These tissue distributions indicate that nascent lipoprotein particles produced in the dog small intestine would contain apoA-I and apoE but not apoC-I. The widespread tissue distribution of apoE mRNA indicates that like other mammals, peripheral synthesis of apoE contributes significantly to the total apoE poo…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ApoE is one of the exchangeable apolipoproteins and is in the same gene family as ApoA1 [144, 145].”
From ApoE lipoproteins in the central nervous system under homeostasis and role in Alzheimer’s disease and related disorders (2026) · cites this paper as [145]
Citations
Cites
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
Innerarity, T. L., & Mahley, R. W. (1978) · Biochemistry · doi:10.1021/bi00601a013 · Cited by 433
Aggerbeck, L. P., Wetterau, J. R., Weisgraber, K. H., Wu, C. S., & Lindgren, F. T. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68779-4 · Cited by 229
Wardell, M. R., Brennan, S. O., Janus, E. D., Fraser, R., & Carrell, R. W. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113096 · Cited by 159
Flagged first, then by citations
Research works printed but not linked: 53
- Mahley, 1984, Plasma lipoprotein: apolipoprotein structure and function, J. Lipid Res., 25, 1277, 10.1016/S0022-2275(20)34443-6 · DOI · Paper page
- Li, 1988, The apolipoprotein multigene family: biosynthesis, structure, structure-function relationships, and evolution, J. Lipid Res., 29, 245, 10.1016/S0022-2275(20)38532-1 · DOI
- Chuang, 1985, Production and characterization of a monoclonal antibody to dog hepatic lipase, Biochim. Biophys. Acta., 833, 69, 10.1016/0005-2760(85)90254-1 · DOI
- Dory, 1985, Heterogeneity of dog interstitial fluid (peripheral lymph) high density lipoproteins: implications for a role in reverse cholesterol transport, J. Lipid Res., 26, 519, 10.1016/S0022-2275(20)34338-8 · DOI
- Barr, 1951, Protein-lipid relationship in human plasma. II. In arteriosclerosis and related conditions, Am. J. Med, 11, 480, 10.1016/0002-9343(51)90183-0 · DOI
- Gofman, 1954, The serum lipoprotein transport system in health, meta-bolic disorders, atherosclerosis and coronary heart disease, Plasma., 2, 413
- Gordon, 1977, High density lipoproteins as a protective factor against coronary heart disease, Am. J. Med., 62, 707, 10.1016/0002-9343(77)90874-9 · DOI · Paper page
- Glomset, 1968, The plasma lecithin:cholesterol acyltransferase reaction, J. Lipid Res., 9, 155, 10.1016/S0022-2275(20)43114-1 · DOI
- Fielding, 1972, A protein cofactor of lecithin:cholesterol acyltransferase, Biochem. Biophys. Res. Commun., 46, 1493, 10.1016/0006-291X(72)90776-0 · DOI
- Fielding, 1972, Lecithin:cholesterol acyltransferase: effects of substrate composition upon enzyme activity, Biochim. Biophys. Acta., 270, 513, 10.1016/0005-2760(72)90116-6 · DOI
- Brown, 1981, Regulation of plasma cholesterol by lipoprotein receptors, Science., 212, 628, 10.1126/science.6261329 · DOI · Paper page
- Sherrill, 1980, Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by high affinity receptor, J. Biol. Chem., 255, 1804, 10.1016/S0021-9258(19)85951-3 · DOI
- Mahley, 1980, Alterations in metabolic activity of plasma lipoproteins following selective chemical modification of the apoproteins, Ann. N Y. Acad Sci., 348, 265, 10.1111/j.1749-6632.1980.tb21306.x · DOI
- Blue, 1983, Apolipoprotein E synthesis in human kidney, adrenal gland, and liver, Proc, Natl. Acad Sci. USA., 80, 283, 10.1073/pnas.80.1.283 · DOI · Paper page
- Elshourbagy, 1984, Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets, Proc. Natl. Acad Sci. USA. USA., 82, 203, 10.1073/pnas.82.1.203 · DOI · Paper page
- Lin-Lee, 1985, Apolipoprotein E gene mapping and expression: localization of the mRNA in lipoprotein and non-lipoprotein producing tissues, Biochemistry., 24, 3751, 10.1021/bi00335a050 · DOI
- Lin, 1986, Immunoreactive apolipoprotein E is a widely distributed cellular protein. Immunohistochemical localization of apolipoprotein E in baboon tissues, J. Clin. Invest., 78, 947, 10.1172/JCI112685 · DOI
- Ignatius, 1987, Lipoprotein uptake by neuronal growth cones in vitro, Science., 236, 959, 10.1126/science.3576212 · DOI
- Avila, 1982, Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells, J. Biol. Chem, 257, 5900, 10.1016/S0021-9258(19)83864-4 · DOI
- Mahley, 1988, Apolipoprotein E: cholesterol transport protein with expanding role in cell biology, Science., 240, 522, 10.1126/science.3283935 · DOI · Paper page
- Soutar, 1975, Effect of the human apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin:cholesterol acyltransferase, Biochemistry., 14, 3057, 10.1021/bi00685a003 · DOI
- Chirgwin, 1979, Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry., 18, 5294, 10.1021/bi00591a005 · DOI
- Aviv, 1972, Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose, Proc. Nail. Acad Sci. USA., 69, 1408, 10.1073/pnas.69.6.1408 · DOI
- Gubler, 1983, A simple and very efficient method for generating cDNA libraries, Gene., 25, 263, 10.1016/0378-1119(83)90230-5 · DOI
- Sanger, 1980, Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing, J. MoL Biol., 143, 161, 10.1016/0022-2836(80)90196-5 · DOI
- Gordon, 1983, Proteolytic processing of human preproapolipoprotein A-I: a proposed defect in the conversion of proA-I to A-I in Tangier disease, J. Biol. Chem, 258, 4037, 10.1016/S0021-9258(18)32773-X · DOI
- Zannis, 1983, Intracellular and extracellular processing of human apolipoprotein A-I: secreted apolipoprotein A-I isoprotein 2 is a proprotein, Proc. Natl. Acad Sci. USA., 80, 2478, 10.1073/pnas.80.9.2574 · DOI
- Chung, 1982, The covalent structure of apolipoprotein A-I from canine high density lipoproteins, J. Biol. Chem., 257, 2961, 10.1016/S0021-9258(19)81058-X · DOI
- Weisgraber, 1980, Comparison of the human, canine and swine E apoproteins, Biochem Biophys. Res. Commun., 95, 374, 10.1016/0006-291X(80)90748-2 · DOI
- Wu, 1979, Relative contributions by liver and intestine to individual plasma apolipoproteins, J. Biol. Chem., 254, 7316, 10.1016/S0021-9258(18)50321-5 · DOI
- Datta, 1987, Structure and expression of dog apolipoprotein C-II and C-III mRNAs: implications for the evolution and functional constraints of apolipoprotein structure, J. Biol. Chem., 262, 10588, 10.1016/S0021-9258(18)61003-8 · DOI
- Matsumoto, 1987, Cloning and regulation of rat apolipoprotein B mRNA, Biochem Biophys. Res. Commun., 142, 92, 10.1016/0006-291X(87)90455-4 · DOI
- Chen, 1986, The complete cDNA and amino acid sequence of human apolipoprotein B- 100, J. Biol. Chem, 261, 12918, 10.1016/S0021-9258(18)69248-8 · DOI
- Kirchgessner, 1987, Regulation of chicken apolipoprotein B: cloning, tissue distribution, and estrogen induction of mRNA, Gene., 59, 241, 10.1016/0378-1119(87)90332-5 · DOI
- Cheung, 1983, Nucleotide sequence of cloned cDNA of human apolipoprotein A-I, Nucleic Acids Res., 11, 3703, 10.1093/nar/11.11.3703 · DOI
- Byrnes, 1987, Chicken apolipoprotein A-I: cDNA sequence, expression and evolution, Biochem Bioplys. Res. Commun., 148, 485, 10.1016/0006-291X(87)91137-5 · DOI
- Luo, 1986, Structure and evolution of the apolipoprotein multigene family, J Mol. Biol., 187, 325, 10.1016/0022-2836(86)90436-5 · DOI · Paper page
- Lauer, 1988, Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene, J. Biol. Chem., 263, 7277, 10.1016/S0021-9258(18)68638-7 · DOI
- Britten, 1988, Sources and evolution of human Alu repeated sequences, Proc. Natl. Acad. Sci. USA., 85, 4770, 10.1073/pnas.85.13.4770 · DOI
- Li, 1987, An evaluation of the molecular clock hypothesis using mammalian DNA sequences, J. Mol. Evol., 25, 330, 10.1007/BF02603118 · DOI
- Dory, 1986, Peripheral synthesis and isoform distribution of dog apoprotein E: an in vivo approach, J. Biol. Chem., 261, 811, 10.1016/S0021-9258(17)36168-9 · DOI
- Pitas, 1987, Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E (LDL) receptors in the brain, J. Biol. Chem., 262, 14352, 10.1016/S0021-9258(18)47945-8 · DOI · Paper page
- Pownall, 1980, Activation of lecithin:cholesterol acyltransferase by a synthetic model lipid-associating peptide, Proc. Natl. Acad Sci. USA., 77, 3154, 10.1073/pnas.77.6.3154 · DOI
- Wetterau, 1988, Human apolipoprotein E3 in aqueous solution. I. Guidance for two structural domains, J. Biol. Chem., 263, 6240, 10.1016/S0021-9258(18)68778-2 · DOI · Paper page
- Mahley, 1983, Lipoprotein receptors and cholesterol homeostasis, Biochim. Biophys. Acta., 737, 197, 10.1016/0304-4157(83)90001-1 · DOI
- Lalazar, 1988, Site specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions, J. Biol Chem., 263, 3542, 10.1016/S0021-9258(18)68957-4 · DOI · Paper page
- Knott, 1985, Human apolipoprotein B: structure of carboxylterminal domains, sites of gene expression, and chromosomal localization, Science., 230, 37, 10.1126/science.2994225 · DOI
- Yang, 1986, Sequence, structure, receptor binding domains and internal repeats of human apolipoprotein B-100, Nature., 323, 738, 10.1038/323738a0 · DOI
- Hobbs, 1986, Deletion of exon encoding cysteine-rich repeat of low density lipoprotein receptor alters its binding specificity in a subject with familial hypercholesterolemia, J. Biol. Chem., 261, 13114, 10.1016/S0021-9258(18)69278-6 · DOI
- Esser, 1988, Mutational analysis of the ligand binding domain of low density lipoprotein receptor, J. Biol Chem., 263, 13282, 10.1016/S0021-9258(18)37702-0 · DOI · Paper page
- Knott, 1986, Complete protein sequence and identification of structural domains of human apolipoprotein B, Nature., 323, 734, 10.1038/323734a0 · DOI
- Fitch, 1967, Construction of phylogenetic trees. A method based on mutation distances as estimated from cytochrome C sequences is of general applicability, Science., 155, 279, 10.1126/science.155.3760.279 · DOI
- Romer, A. S. 1966. Vertebrate Paleontology, University of Chicago Press, Chicago.
Cited by
Sorted by citations
Apolipoprotein E: Structure-Function Relationships
Weisgraber, K. H. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60642-7 · Cited by 830
Dong, L. M., Wilson, C., Wardell, M. R., Simmons, T., Mahley, R. W., Weisgraber, K. H., & Agard, D. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31797-0 · Cited by 320
Strickland, M. R., & Holtzman, D. M. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00970-0
Metadata
- Authors
- Luo, C. C., Li, W. H., & Chan, L.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 1989-11
- Volume
- 30
- Issue
- 11
- Pages
- 1735-1746
- ISSN
- 0022-2275
- Cited by
- 41
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review